BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 11583061)

  • 1. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Dig Dis; 2000; 18(2):93-102. PubMed ID: 11060472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy for gastroesophageal reflux disease.
    Arora AS; Castell DO
    Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease.
    Tolman KG; Chandramouli J; Fang JC
    Expert Opin Pharmacother; 2000 Sep; 1(6):1171-94. PubMed ID: 11249486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.
    Tighe MP; Afzal NA; Bevan A; Beattie RM
    Paediatr Drugs; 2009; 11(3):185-202. PubMed ID: 19445547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatments of GERD: the old and new.
    Vela MF
    Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management and treatment of gastroesophageal reflux disease.
    Storr M; Meining A
    Dis Esophagus; 2004; 17(3):197-204. PubMed ID: 15361091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical guidelines of diagnosis and treatment of gastroesophageal reflux disease].
    Rev Gastroenterol Mex; 2007; 72(2):163-76. PubMed ID: 17966380
    [No Abstract]   [Full Text] [Related]  

  • 14. New pharmacologic approaches in gastroesophageal reflux disease.
    Armstrong D; Sifrim D
    Gastroenterol Clin North Am; 2010 Sep; 39(3):393-418. PubMed ID: 20951909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G
    Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and treatment of gastro-oesophageal reflux disease.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 165():7-12; discussion 27-8. PubMed ID: 2574907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.
    Hershcovici T; Fass R
    Drugs; 2011 Dec; 71(18):2381-9. PubMed ID: 22117130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease. The long and the short of therapeutic options.
    Brady WM; Ogorek CP
    Postgrad Med; 1996 Nov; 100(5):76-80, 85-6, 89. PubMed ID: 8917326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.